Trial
NCT04256148
ALXN1830 in Patients With Warm Autoimmune Hemolytic Anemia
Phase IIWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
Alexion Pharmaceuticals, Inc.
Collaborators
—
Condition
Warm Autoimmune Hemolytic Anemia
Intervention
ALXN1830
Why stopped
Study is withdrawn due to the global impact of the COVID-19 pandemic.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2020-07-13